194 related articles for article (PubMed ID: 8059696)
1. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
[TBL] [Abstract][Full Text] [Related]
2. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
Farrer M; Game FL; Albers CJ; Neil HA; Winocour PH; Laker MF; Adams PC; Alberti KG
Arterioscler Thromb; 1994 Aug; 14(8):1272-83. PubMed ID: 8049188
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
[TBL] [Abstract][Full Text] [Related]
5. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
Gupta R; Vasisht S; Bahl VK; Wasir HS
Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study.
Klausen IC; Sjøl A; Hansen PS; Gerdes LU; Møller L; Lemming L; Schroll M; Faergeman O
Atherosclerosis; 1997 Jul; 132(1):77-84. PubMed ID: 9247362
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
[TBL] [Abstract][Full Text] [Related]
9. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
[TBL] [Abstract][Full Text] [Related]
10. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
Nieminen MS; Mattila KJ; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen MR
Arterioscler Thromb; 1992 Jan; 12(1):58-69. PubMed ID: 1346250
[TBL] [Abstract][Full Text] [Related]
11. Lipid abnormalities in Greek patients with coronary artery disease.
Elisaf MS; Siamopoulos KC; Tselegarides TJ; Bairaktari ETh ; Goudevenos JA; Tselepis AD; Tsolas OE; Sideris DA
Int J Cardiol; 1997 Apr; 59(2):177-84. PubMed ID: 9158172
[TBL] [Abstract][Full Text] [Related]
12. Relation between lipoprotein (a) and in vitro oxidation of apolipoprotein B-containing lipoproteins.
Serdar Z; Sarandöl E; Dirican M; Yeşilbursa D; Serdar A; Tokullugil A
Clin Biochem; 2000 Jun; 33(4):303-9. PubMed ID: 10936590
[TBL] [Abstract][Full Text] [Related]
13. Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases.
Abe A; Noma A; Lee YJ; Yamaguchi H
Atherosclerosis; 1992 Sep; 96(1):9-15. PubMed ID: 1418106
[TBL] [Abstract][Full Text] [Related]
14. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
Azizi F; Rahmani M; Raiszadeh F; Solati M; Navab M
Coron Artery Dis; 2002 Feb; 13(1):9-16. PubMed ID: 11917194
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
17. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
18. [Apolipoprotein (a) polymorphism in relation to coronary heart disease in Chinese Han nationality].
Qin S; Wang S; Li C
Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):588-91, 637-8. PubMed ID: 8697071
[TBL] [Abstract][Full Text] [Related]
19. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062
[TBL] [Abstract][Full Text] [Related]
20. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
